Literature DB >> 25407705

The cancer that rises with the sun.

David Holmes.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25407705     DOI: 10.1038/515S110a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Attenuated Salmonella engineered with an apoptosis-inducing factor (AIF) eukaryotic expressing system enhances its anti-tumor effect in melanoma in vitro and in vivo.

Authors:  Huan Wang; Tingtao Chen; Linxi Wan; Jiachen Lu; Hong Wei; Ke-Yu Deng; Jing Wei; Hong-Bo Xin
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-24       Impact factor: 4.813

2.  BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors.

Authors:  Deon B Doxie; Allison R Greenplate; Jocelyn S Gandelman; Kirsten E Diggins; Caroline E Roe; Kimberly B Dahlman; Jeffrey A Sosman; Mark C Kelley; Jonathan M Irish
Journal:  Pigment Cell Melanoma Res       Date:  2018-06-28       Impact factor: 4.693

3.  INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.

Authors:  Yang Yu; Run Huang; Xiangyun Zong; Xiangming He; Wenju Mo
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

Review 4.  Prospect of Human Pluripotent Stem Cell-Derived Neural Crest Stem Cells in Clinical Application.

Authors:  Qian Zhu; Qiqi Lu; Rong Gao; Tong Cao
Journal:  Stem Cells Int       Date:  2016-12-20       Impact factor: 5.443

5.  Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression.

Authors:  Jiaojiao Zhao; Zhengkui Zhang; Yaxian Xue; Guoqun Wang; Yuan Cheng; Yuchen Pan; Shuli Zhao; Yayi Hou
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

Review 6.  Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.

Authors:  Dorina Coricovac; Cristina Dehelean; Elena-Alina Moaca; Iulia Pinzaru; Tiberiu Bratu; Dan Navolan; Ovidiu Boruga
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

7.  Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.

Authors:  Yongxia Zhu; Tinghong Ye; Xi Yu; Qian Lei; Fangfang Yang; Yong Xia; Xuejiao Song; Li Liu; Hongxia Deng; Tiantao Gao; Cuiting Peng; Weiqiong Zuo; Ying Xiong; Lidan Zhang; Ningyu Wang; Lifeng Zhao; Yongmei Xie; Luoting Yu; Yuquan Wei
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

8.  Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.

Authors:  Eri Adachi; Katsuya Sakai; Takumi Nishiuchi; Ryu Imamura; Hiroki Sato; Kunio Matsumoto
Journal:  Oncotarget       Date:  2016-10-25

9.  Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population.

Authors:  Luz D Gutiérrez-Castañeda; Mauricio Gamboa; John A Nova; Leonardo Pulido; Jose D Tovar-Parra
Journal:  Biomed Res Int       Date:  2020-07-22       Impact factor: 3.411

10.  The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.

Authors:  Huijie Jia; Wenjing Ren; Yuchen Feng; Tian Wei; Mengmeng Guo; Jing Guo; Jingjing Zhao; Xiangfeng Song; Mingyong Wang; Tiesuo Zhao; Hui Wang; Zhiwei Feng; Zhongwei Tian
Journal:  Int J Oncol       Date:  2018-07-06       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.